BLFS - biolifesolutions.com Book Valuation of Business

Public company logo of biolifesolutions.com (BLFS)

BioLife Solutions, Inc. (BLFS) is implementing automated AI systems to create sterile environments and control packaging. This chart of BLFS stock quotes demonstrates the price action of an asset with a market capitalization of 0.42. The business specializes in advanced cell freezing methods and cloud services, investing heavily in scientific research and development. However, reliance on a limited number of customers and declining sector investment create challenges for scaling.

biolifesolutions.com (BLFS) - Company Book Value from 07/04/2022 to 10/18/2026
Mass-produced product of BioLife Solutions Inc

The innovative potential of BioLife Solutions, Inc. (BLFS) and its commitment to GMP standards are reflected in the accounting capitalization trend. This indicator distinguishes the objective value of the business from market expectations. The metric is calculated as the sum of net assets minus all debt obligations. The stability of this metric confirms the resilience of the company's fundamental base. For the investor, such price action serves as a filter against overpaying for a volatile asset.

Key competitors

TEM: Net Asset Value|Qiagen N.V. - Company Book Value|ionispharma.com (IONS) - Book Valuation of Business|Book Capitalization Repligen (RGEN)|Accounting Capitalization RNA|Company Book Value CRISPR Therapeutics Corp CRSP|Accounting Capitalization GeneDx Corp (WGS)|Book Capitalization RARE (Ultragenyx Pharmaceutical)|Book Capitalization beamtx.com BEAM|SRPT - Book Capitalization|TWST - Company Book Value|10x Genomics Corp - Book Capitalization|NTLA (Intellia Corp) - Book Valuation of Business|Company Book Value STOK (Stoke Therapeutics)|Total Stockholders' Equity WVE|Company Book Value Maze Therapeutics (MAZE)|Company Book Value Sionna Therapeutics, Inc. (SION)|Book Capitalization PRME|Book Valuation of Business Taysha Corp TSHA|Book Capitalization uniQure N.V.|MGTX - Net Asset Value|Book Capitalization RGNX|Total Stockholders' Equity Solid Biosciences Inc|OCGN - Company Net Assets|Accounting Value of Company PACB|BNTC (Benitec Biopharma Inc.) - Company Book Value|Book Valuation of Business DSGN (designtx.com)|RCKT: Company Book Value|4DMT - Total Stockholders' Equity|LXEO - Company Book Value|Korro Bio, Inc. (KRRO) - Company Book Value|EDIT: Company Net Assets|Book Capitalization silence-therapeutics.com|ProQR (PRQR) - Company Net Assets|Total Net Assets Codexis Bio|SGMO (Sangamo) - Book Capitalization|Book Valuation of Business NAUT (nautilus.bio)|MGX: Company Book Value|Precision BioSciences Inc. - Total Stockholders' Equity|Generation Bio Corp (GBIO) - Company Book Value|BOLD: Accounting Capitalization|exicuretx.com - Company Book Value|Book Valuation of Business Imunon|PHIO - Company Net Assets|Accounting Value of Company Mustang Bio Corp|RNAZ (TransCode Therapeutics) - Book Capitalization|Book Valuation of Business BNGO (bionanogenomics.com)|APDN - Company Book Value|Accounting Capitalization bluebird bio, Inc BLUE|IPA: Book Capitalization|omegatherapeutics.com (OMGA) - Company Net Assets|Singular Genomics - Company Net Assets|Regulus Therapeutics, Inc. (RGLS) - Book Valuation of Business|Book Capitalization Syros|Company Book Value TBIO|Company Book Value TRACON Pharmaceuticals (TCON)|Company Book Value unitybiotechnology.com (UBX)